Asymmetrical flow field-flow fractionation (AF4) separates peptides and their aggregates by size in an open channel, without a packed stationary phase, complementing SEC and light-scattering methods in the analytical laboratory.

What AF4 shows: A cross-flow field drives species toward a membrane while diffusion pushes back, so smaller species elute earlier than larger ones. Coupled to UV, MALS, and DLS detectors, AF4 can characterize monomer, oligomer, and aggregate populations across a wide size range under relatively gentle conditions.

Use in a QC workflow: AF4 is typically paired with SEC, analytical HPLC, and mass spectrometry so size-distribution findings are cross-checked against purity and identity data. Method development must address membrane interactions, sample recovery, focus conditions, and detector calibration, and every result should report recovery alongside the size distribution.

Limitations: AF4 is method-sensitive and recovery-dependent; a missing population can reflect membrane loss rather than absence in the sample. It supports, but does not replace, HPLC and mass spectrometry identity and purity testing.

Disclaimer: For laboratory research purposes only. Not for human consumption. The methods described are analytical laboratory techniques; no medical or therapeutic claim is made.

Citations: Standard AF4 methods literature for biomolecular size separation and MALS detection.